Improving our Understanding of Early Psychosis: Learning from the Optimise Trial. (2023)
Attributed to:
Identifying the prevalence of antibodies to neuronal membrane targets in first episode psychosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/schbul/sbad061
PubMed Identifier: 37159930
Publication URI: http://europepmc.org/abstract/MED/37159930
Type: Journal Article/Review
Volume: 49
Parent Publication: Schizophrenia bulletin
Issue: 4
ISSN: 0586-7614